# Batterson Venture Capital

> Batterson Venture Capital is a VC fund backing Biopharma and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Chicago, United States
- Total investments: 1
- Last investment: Jun 2016
- Lead investor: 0%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/battersonvc
- Website: http://battersonvc.com

Batterson Venture Capital is an investment fund that is focused on entrepreneurial seed, startup, and early-stage companies. The firm seeks to invest in media, healthcare, and technology sectors. It was founded in 2014 and is based in Chicago, Illinois, United States.

## Contacts

5 contacts available for Batterson Venture Capital. Shizune tracks 3 team members at Batterson Venture Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/batterson-venture-capita?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Annie Piotrowski | Vice President & Office Administrator | 0 | https://shizune.co/investors/profile/annie-piotrowski |
| Chris LoPresti | Venture Strategist | 0 | https://shizune.co/investors/profile/chris-lopresti |
| James Vaughan | Managing Principal | 0 | https://shizune.co/investors/profile/james-vaughan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Intensity Therapeutics | Intensity Therapeutics, Inc., a biopharmaceutical company, provides chemotherapy treatments for cancer patients. It engages in the direct intratumoral injection of novel pharmaceutical formulations for cancer administration. Intensity Therapeutics, Inc. was incorporated in 2012 and is based in Norwalk, Connecticut. | $10M | Series A | Jun 28, 2016 |  |

1 of 1 investments shown.

## Co-investors
- [SalvaRx Group PLC](https://shizune.co/investors/profile/salvarx-group-plc) — VC Fund, 1 deal together
- [VCapital](https://shizune.co/investors/profile/vcapital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Batterson Venture Capital invest in?

Batterson Venture Capital invests primarily in Biopharma, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Batterson Venture Capital?

Public channels for Batterson Venture Capital include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Batterson Venture Capital?

The team at Batterson Venture Capital includes Annie Piotrowski (Vice President & Office Administrator), Chris LoPresti (Venture Strategist) and James Vaughan (Managing Principal). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co